Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Neuromyelitis Optica 1Myelitis, Transverse 1Myelitis 1Gastrointestinal Stromal Tumors 1Erectile Dysfunction 1

Interventions

Sildenafil Citrate 9Tadalafil 4Surveys and Questionnaires 2Pentoxifylline 2Alprostadil 2udenafil 1mirabegron 1methyl 3-mercaptopropionimidate 1bicalutamide 1alpha-Tocopherol 1Yoga 1Vitamin E 1Tamoxifen 1Tacrolimus 1Tablets 1Surgical Instruments 1Saline Solution 1Restraint, Physical 1Psychiatric Rehabilitation 1Preservation, Biological 1Menogaril 1Long-Term Synaptic Depression 1Laparoscopy 1Intraoperative Neurophysiological Monitoring 1Indocyanine Green 1Holistic Health 1High-Intensity Focused Ultrasound Ablation 1GPI 1485 1Exercise 1Erythropoietin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Erectile Dysfunction × 4-Aminopyridine × Clear all
NCT03701581 2025-12-17

4-aminopyridine Treatment for Nerve Injury

University of Arizona

Phase 2/3 Recruiting
70 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡